pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·Jul 27·1 min read
save

Nokia board member Timo Ihamuotila purchases 33,700 shares at around €8.45 each

Jul 27, 2026·read at globenewswire health ↗Neutral

On July 24, 2026, Timo Ihamuotila, a member of Nokia Corporation's board, executed multiple share purchases.

He acquired 24,340 shares on the BEUP venue at a price of €8.4449 per share.

Additional acquisitions included 4,506 shares on the CEUD venue at €8.4444 per share and 4,854 shares on the CEUX venue at €8.4612 per share.

The transactions were reported as an initial notification under Article 19 of the EU Market Abuse Regulation.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Nokia Corporation - Managers' transactions (Ihamuotila)”

read at globenewswire health ↗
245 words · retrieved Jul 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • Aug 10Aspo Oyj - Johdon liiketoimetglobenewswire health
  • Aug 10Aspo Plc - Managers' Transactionsglobenewswire health
  • Aug 7Ledende medarbejder transaktionglobenewswire health
  • Aug 7Ledende medarbejders køb af aktierglobenewswire health
  • Aug 6Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officerglobenewswire health